Hungary
Tuberculosis profile
Population  2013 10 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.081 (0.081–0.081) 0.81 (0.81–0.81)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0–0.02)
Prevalence  (includes HIV+TB) 2.9 (1.5–4.7) 29 (15–48)
Incidence  (includes HIV+TB) 1.8 (1.7–2) 18 (17–20)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.03–0.08)
Case detection, all forms (%) 58 (53–63)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.5 (1.3–4.3) 8.1 (3.3–16)
MDR-TB cases among notified pulmonary
TB cases
23 (12–40) 6 (2–11)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 430   24
Pulmonary, clinically diagnosed 499   38
Extrapulmonary 46   3
       
Total new and relapse 1 040    
Previously treated, excluding relapses 5    
Total cases notified 1 045    
Among 1 040 new and relapse cases:
7 (<1%) cases aged under 15 years; male:female ratio: 1.8
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 408 (95%) 54 (77%) 462
Laboratory-confirmed RR-/MDR-TB cases     11
Patients started on MDR-TB treatment     10
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 70
Previously treated cases, excluding relapse, registered in 2012 53
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 43
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 3.5
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-03-04 Data: www.who.int/tb/data